Hyperfine, Inc. earnings releases HYPR

Hyperfine, Inc. last reported quarterly results on Oct 8, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026). It usually reports 8–42 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 8–42 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 8, 2026
8 days after quarter end
Q3 FY2026
ended Sep 30, 2026
—
—
—
Aug 6, 2026
37 days after quarter end
Q2 FY2026
ended Jun 30, 2026
4
+44.8%
-9
-0.8%
-0.09
+25.0%
May 12, 2026
42 days after quarter end
Q1 FY2026
ended Mar 31, 2026
4
+82.6%
-9
+8.4%
-0.09
+25.0%
Jan 12, 2026
12 days after quarter end
Q4 FY2025
ended Dec 31, 2025
5
+128.0%
-6
+43.1%
-0.06
+55.9%
Oct 15, 2025
15 days after quarter end
Q3 FY2025
ended Sep 30, 2025
3
-5.7%
-11
-6.7%
-0.14
+0.0%
Aug 13, 2025
44 days after quarter end
Q2 FY2025
ended Jun 30, 2025
3
-25.8%
-9
+9.2%
-0.12
+14.3%
May 13, 2025
43 days after quarter end
Q1 FY2025
ended Mar 31, 2025
2
-35.1%
-9
+4.4%
-0.12
+14.3%
Feb 11, 2025
42 days after quarter end
Q4 FY2024
ended Dec 31, 2024
2
-13.6%
-10
+2.8%
-0.14
+4.4%

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
HYPR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Guilford, CT
SEC filer status
, Emerging growth company
SEC CIK
1833769
Former names
HealthCor Catalio Acquisition Corp. (until Dec 22, 2021)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.